Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

EXCEL-Punjabi: A Culturally Tailored Exercise Oncology Pilot Feasibility Intervention (EXCEL-Punjabi)

8. juni 2026 oppdatert av: University of Calgary

EXCEL-Punjabi: Tailored Exercise Oncology for the South Asian Population

The goal of this pilot feasibility study is to explore the feasibility and exploratory effects of a culturally-tailored exercise oncology intervention in Punjabi-speaking individuals of South Asian heritage and their support persons. The main questions it aims to answer are:

  1. What is the feasibility and acceptability of the EXCEL-Punjabi intervention?
  2. What are the exploratory effects (i.e., psychosocial and physical changes) before and after program delivery?

Participants will take part in a 12-week exercise oncology intervention consisting of twice weekly hour long multimodal circuit-based exercise sessions. They will also complete questionnaires and functional fitness assessments pre- and post- intervention.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

12

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

  • Canada
    • Alberta
      • Calgary, Alberta, Canada, T2N 1N4
        • Genesis Centre Calgary

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria:

  • Punjabi-speaking
  • Self-identified as being of South Asian heritage
  • over the age of 18
  • pre-, post-, or currently receiving cancer treatment or a support person of an individual living with and beyond cancer
  • cleared to participate in, at minimum, mild intensity exercise by a Clinical Exercise Physiologist
  • Able to provide informed consent

Exclusion Criteria:

  • under the age of 18
  • not cleared to exercise by a Clinical Exercise Physiologist

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: EXCEL-Punjabi
Culturally Tailored Exercise Oncology Intervention
Atferdsmessig: EXCEL-Punjabi
Culturally Tailored Exercise Oncology Intervention

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Measurement Completion
Tidsramme: Baseline to the end of the intervention (12 weeks)
Participants who completed all pre- and post- questionnaires and functional assessments
Baseline to the end of the intervention (12 weeks)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Referrals
Tidsramme: Baseline to end of intervention (12 weeks)
Number of participants referred to intervention
Baseline to end of intervention (12 weeks)
Consented
Tidsramme: Recruitment to end of intervention (12 weeks)
Number of participants who consented to participate in the intervention
Recruitment to end of intervention (12 weeks)
Enrolled
Tidsramme: Baseline (week 0)
Number of participants who enrolled (i.e. completed baseline assessments)
Baseline (week 0)
Attendance
Tidsramme: Baseline to end of intervention (12 weeks)
Intervention Attendance
Baseline to end of intervention (12 weeks)
Adverse Events
Tidsramme: Baseline to end of intervention (12 weeks)
Using the standardized Common Terminology Criteria for Adverse Events Version 6.0
Baseline to end of intervention (12 weeks)
Time Required to Deliver and Implement Intervention
Tidsramme: From recruitment to end of intervention (12 weeks)
Time requirement to deliver intervention
From recruitment to end of intervention (12 weeks)
Physical Activity Level
Tidsramme: Baseline to end of intervention (12 weeks)
The Godin Leisure Time Exercise Questionnaire is used to determine subjective levels of physical activity in each participant. Participants report how many times per week they partake in mild, moderate, and/or strenuous exercise. Higher scores indicate a more physically active lifestyle.
Baseline to end of intervention (12 weeks)
Cancer related symptoms
Tidsramme: Baseline to end of intervention (12 weeks)
Change in Edmonton Symptom Assessment Scale - revised: cancer. Scale is from 0-10, where 0 means the symptom is absent and 10 means the worst possible severity of the symptom is being experienced.
Baseline to end of intervention (12 weeks)
Health Related Quality of Life
Tidsramme: Baseline to end of intervention (12 weeks)
Change in EuroQual - 5Dimensions (EQ-5D) tool - first section is a questionnaire; last section uses a scale from 0-100, where 0 means the worst health imaginable and 100 means the best health imaginable.
Baseline to end of intervention (12 weeks)
Fatigue
Tidsramme: Baseline to end of intervention (12 weeks)
Change in Functional Assessment of Chronic Illness Therapy - Fatigue subscale - scale is from 0-4, where 0 means "not at all" and 4 means "very much".
Baseline to end of intervention (12 weeks)
Cancer Related Quality of Life
Tidsramme: Baseline to end of intervention (12 weeks)
A 5-point Likert scale (0 = not at all, to 4 = very much) to track wellbeing over the course of the cancer journey.
Baseline to end of intervention (12 weeks)
Exercise Barriers Self-Efficacy
Tidsramme: Baseline to end of intervention (12 weeks)
Exercise barriers and facilitators questionnaire
Baseline to end of intervention (12 weeks)
Cognition
Tidsramme: Baseline to end of intervention (12 weeks)
Cancer related cognition using the Functional Assessment of Cancer Therapy - Cognition questionnaire. A 37-item, self-report questionnaire used to evaluate how cancer patients perceive their own cognitive abilities
Baseline to end of intervention (12 weeks)
Aerobic Capacity
Tidsramme: Baseline to end of intervention (12 weeks)
In-person participants will be assessed on change in 6-minute walk test (m) results
Baseline to end of intervention (12 weeks)
Aerobic Capacity
Tidsramme: Baseline to end of intervention (12 weeks)
Online participants will be assessed with change in the 2-minute step test (number of steps) results.
Baseline to end of intervention (12 weeks)
Lower body strength
Tidsramme: Baseline to end of intervention (12 weeks)
Change in sit-to-stand (number of repetitions in 30 seconds)
Baseline to end of intervention (12 weeks)
Upper extremity flexibility
Tidsramme: Baseline to end of intervention (12 weeks)
Change in active shoulder flexion range of motion (degrees)
Baseline to end of intervention (12 weeks)
Balance
Tidsramme: Baseline to end of intervention (12 weeks)
Change in one legged stance test (seconds)
Baseline to end of intervention (12 weeks)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

University of Calgary

Samarbeidspartnere

Canadian Institutes of Health Research (CIHR)

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Hjelpsomme linker

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. juli 2025

Primær fullføring (Faktiske)

12. desember 2025

Studiet fullført (Faktiske)

12. desember 2025

Datoer for studieregistrering

Først innsendt

11. mai 2026

Først innsendt som oppfylte QC-kriteriene

8. juni 2026

Først lagt ut (Faktiske)

11. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

11. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

8. juni 2026

Sist bekreftet

1. mai 2026

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • HREBA.CC-25-0150

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Aggregate and participant-level results are reported within publications, but there is no formal plan for external IPD sharing. With a small sample size from a specific cultural group, there may be risk of re-identification.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på EXCEL-Punjabi

Søk i lignende forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

CROs by country

CROs in Czech Republic

Forhold

Sjeldne sykdommer

Legemiddelintervensjoner

Kosttilskudd

Sponsor / samarbeidspartnere

Steder

Abonnere